| pubmed-article:16678649 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16678649 | lifeskim:mentions | umls-concept:C0002658 | lld:lifeskim |
| pubmed-article:16678649 | lifeskim:mentions | umls-concept:C0012634 | lld:lifeskim |
| pubmed-article:16678649 | lifeskim:mentions | umls-concept:C0424295 | lld:lifeskim |
| pubmed-article:16678649 | lifeskim:mentions | umls-concept:C0036140 | lld:lifeskim |
| pubmed-article:16678649 | lifeskim:mentions | umls-concept:C0076823 | lld:lifeskim |
| pubmed-article:16678649 | lifeskim:mentions | umls-concept:C0687676 | lld:lifeskim |
| pubmed-article:16678649 | lifeskim:mentions | umls-concept:C0030685 | lld:lifeskim |
| pubmed-article:16678649 | lifeskim:mentions | umls-concept:C0680255 | lld:lifeskim |
| pubmed-article:16678649 | lifeskim:mentions | umls-concept:C0282440 | lld:lifeskim |
| pubmed-article:16678649 | lifeskim:mentions | umls-concept:C0391871 | lld:lifeskim |
| pubmed-article:16678649 | lifeskim:mentions | umls-concept:C1283071 | lld:lifeskim |
| pubmed-article:16678649 | lifeskim:mentions | umls-concept:C1096777 | lld:lifeskim |
| pubmed-article:16678649 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
| pubmed-article:16678649 | lifeskim:mentions | umls-concept:C1963578 | lld:lifeskim |
| pubmed-article:16678649 | lifeskim:mentions | umls-concept:C0205430 | lld:lifeskim |
| pubmed-article:16678649 | lifeskim:mentions | umls-concept:C1515021 | lld:lifeskim |
| pubmed-article:16678649 | lifeskim:mentions | umls-concept:C0231449 | lld:lifeskim |
| pubmed-article:16678649 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:16678649 | pubmed:dateCreated | 2006-5-8 | lld:pubmed |
| pubmed-article:16678649 | pubmed:abstractText | Because the scientific literature on the pharmacotherapy of attention-deficit/hyperactivity disorder (ADHD) is almost entirely based on the results of studies in samples consisting primarily of boys, much is unknown about the treatment response in girls. | lld:pubmed |
| pubmed-article:16678649 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16678649 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16678649 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16678649 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16678649 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16678649 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16678649 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16678649 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16678649 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16678649 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16678649 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16678649 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:16678649 | pubmed:issn | 0149-2918 | lld:pubmed |
| pubmed-article:16678649 | pubmed:author | pubmed-author:BiedermanJose... | lld:pubmed |
| pubmed-article:16678649 | pubmed:author | pubmed-author:SpencerThomas... | lld:pubmed |
| pubmed-article:16678649 | pubmed:author | pubmed-author:McGoughJames... | lld:pubmed |
| pubmed-article:16678649 | pubmed:author | pubmed-author:WigalSharon... | lld:pubmed |
| pubmed-article:16678649 | pubmed:author | pubmed-author:MaysDavid ADA | lld:pubmed |
| pubmed-article:16678649 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16678649 | pubmed:volume | 28 | lld:pubmed |
| pubmed-article:16678649 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16678649 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16678649 | pubmed:pagination | 280-93 | lld:pubmed |
| pubmed-article:16678649 | pubmed:meshHeading | pubmed-meshheading:16678649... | lld:pubmed |
| pubmed-article:16678649 | pubmed:meshHeading | pubmed-meshheading:16678649... | lld:pubmed |
| pubmed-article:16678649 | pubmed:meshHeading | pubmed-meshheading:16678649... | lld:pubmed |
| pubmed-article:16678649 | pubmed:meshHeading | pubmed-meshheading:16678649... | lld:pubmed |
| pubmed-article:16678649 | pubmed:meshHeading | pubmed-meshheading:16678649... | lld:pubmed |
| pubmed-article:16678649 | pubmed:meshHeading | pubmed-meshheading:16678649... | lld:pubmed |
| pubmed-article:16678649 | pubmed:meshHeading | pubmed-meshheading:16678649... | lld:pubmed |
| pubmed-article:16678649 | pubmed:meshHeading | pubmed-meshheading:16678649... | lld:pubmed |
| pubmed-article:16678649 | pubmed:meshHeading | pubmed-meshheading:16678649... | lld:pubmed |
| pubmed-article:16678649 | pubmed:meshHeading | pubmed-meshheading:16678649... | lld:pubmed |
| pubmed-article:16678649 | pubmed:meshHeading | pubmed-meshheading:16678649... | lld:pubmed |
| pubmed-article:16678649 | pubmed:meshHeading | pubmed-meshheading:16678649... | lld:pubmed |
| pubmed-article:16678649 | pubmed:meshHeading | pubmed-meshheading:16678649... | lld:pubmed |
| pubmed-article:16678649 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16678649 | pubmed:articleTitle | A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention-deficit/hyperactivity disorder. | lld:pubmed |
| pubmed-article:16678649 | pubmed:affiliation | Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA. jbiederman@partners.org | lld:pubmed |
| pubmed-article:16678649 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16678649 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:16678649 | pubmed:publicationType | Multicenter Study | lld:pubmed |
